Synectics Regulatory News (SNX)

22 Oct 2007 10:46

Synexus Clinical Research PLC22 October 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): SYNEXUS CLINICAL RESEARCH PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: (YES) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation (iii): NEWTON INVESTMENT MANAGEMENT LIMITED 4. Full name of shareholder(s) (if different from 3.) (iv): 5. Date of the transaction (and date on which the threshold is crossed orreached if different) (v): 18/10/07 6. Date on which issuer notified: 19/10/07 7. Threshold(s) that is/are crossed or reached: DECREASE FROM 9.00% TO 8.83% 8. Notified details: SALE OF 38,461 SHARES A: Voting rights attached to shares Class/type of shares if possible using Situation previous to the Triggeringthe ISIN CODE transaction (vi) Number of Number of voting Rights shares (viii) ORDINARY SHARES 2,083,861 9.00%GB00B0L2P93 Resulting situation after the triggering transaction (vii) Class/type of shares if possible Number of Number of voting % of votingusing the ISIN CODE shares rights (ix) rights Direct Direct Indirect Direct Indirect (x) (xi) ORDINARY SHARES N/A N/A 2,045,400 N/A 8.83%GB00B0L2P93 B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of Expiration Exercise/ Number of voting rights that may % offinancial Date Conversion be acquired if the instrument is votinginstrument (xiii) Period/ Date exercised/ converted. rights (xiv) Total (A+B)Number of voting rights % of voting rights 2,045,400 8.83% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): NEWTON INVESTMENT MANAGEMENT HOLDS THESE SHARES AS DISCRETIONARY INVESTMENTMANAGERS Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: 14. Contact name: ASIF S LALANI 15. Contact telephone number: +44 (0)20 7163 5115 This information is provided by RNS The company news service from the London Stock Exchange